Drugs / ND0612
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02604914 | May 2015 → Jun 2016 | Parkinson disease | NeuroDerm Ltd. | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02726386 | May 2016 → Sep 2019 overdue | Parkinson disease | NeuroDerm Ltd. | Active not recruiting | No outcome recorded |
| Phase 2 | NCT01883505 | Jan 2014 → Apr 2015 | Parkinson disease | NeuroDerm Ltd. | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT04006210 | Sep 2019 → Nov 2022 overdue | Parkinson disease | NeuroDerm Ltd. | Active not recruiting | No outcome recorded |
| Phase 3 | NCT03462043 | Apr → Nov 2018 | Parkinson disease | NeuroDerm Ltd. | Withdrawn | No outcome recorded |
| Phase 3 | NCT02782481 | Aug 2016 → Oct 2018 | Parkinson disease | NeuroDerm Ltd. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ND0612 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02604914 ↗ |
| Route | Subcutaneous | “Subcutaneous infusion via CRONO ND pump” NCT01883505 ↗ |